Ledlie, S., et al. (2023). Assessing the impact of the slow-release oral morphine drug shortages in Ontario, Canada: A population-based time series analysis | International Journal of Drug Policy
Rosic, T., et al. (2023). Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021 | JAMA Open Network Substance Use and Addiction
McAdam, E., et al. (2023). Decriminalization thresholds for drug possession: A multi-criteria policy analysis framework | International Journal of Drug Policy
Xavier, C. G., et al. (2023). Association between toxic drug events and encephalopathy in British Columbia, Canada: a cross-sectional analysis | Substance Abuse Treatment, Prevention, and Policy
Chatterton, C. N., & Handy, R. P. (2023). Fentanyl concentrations in ligated femoral blood in the presence and absence of NPS benzodiazepine drugs. A review of over 1250 benzo-dope / fentanyl toxicity cases in Alberta, Canada | Forensic Science International
Ziegler, B. R., et al. (2023). The ever-changing narrative: Supervised injection site policy making in Ontario, Canada | International Journal of Drug Policy
Mitra, S., et al. (2023). Socioeconomic marginalization and risk of overdose in a community-recruited cohort of people who use drugs: A longitudinal analysis | International Journal of Drug Policy
McKnight, C., et al. (2023). Understanding intentionality of fentanyl use and drug overdose risk: Findings from a mixed methods study of people who inject drugs in New York City | International Journal of Drug Policy
Kenny, K. S., et al. (2023). Association of Illicit Fentanyl Use with Injection Risk Practices Among People who Inject Drugs | AIDS and Behavior
Rioux, W., et al. (2023). Virtual overdose monitoring services and overdose prevention technologies: Opportunities, limitations, and future directions | International journal of Drug Policy
Ali, F., et al. (2023). Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study | Harm Reduction Journal
Palis, H., & MacDonald, S. (2023). Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada | Canadian Medical Association Journal
Dertadian, G. C. (2023). Is non-medical use normal? Normalisation, medicalisation and pharmaceutical consumption | International Journal of Drug Policy
Barker, B., et al. (2023). Opioid agonist therapy and mortality among First Nations and other residents with concurrent alcohol use disorder in British Columbia, Canada: A population-based cohort study | Drug and Alcohol Dependence
Meyer, M., et al. (2023). Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study | Addiction Science & Clinical Practice
Powell, D., et al. (2023). Understanding the rise in overdose deaths involving opioids and non-opioid prescription drugs in the United States | International Journal of Drug Policy
Michaud, L., & van der Meulen, E. (2023). “They’re Just Watching You All the Time”: The Surveillance Web of Prison Needle Exchange | Surveillance and Society
Khatri, U. G., et al. (2023). “A Lack of Empathy:” A qualitative study of Black people seeking treatment for opioid use disorder | SSM Qualitative Research in Health
Hulsey, J., et al. (2023). Stigmatizing imagery for substance use disorders: a qualitative exploration | Health & Justice
Forchuk, C., et al. (2023). People with lived and living experience of methamphetamine use and admission to hospital: what harm reduction do they suggest needs to be addressed? | Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice
Carver, H., et al. (2023). 'It’s not going to be a one size fits all': a qualitative exploration of the potential utility of three drug checking service models in Scotland | Harm Reduction Journal
Cooke, A., et al. (2023). The intersection of drug use discrimination and racial discrimination in the management of chronic non-cancer pain in United States primary care safety-net clinics: Implications for healthcare system and clinic-level changes | Drug and Alcohol Dependence
Molina, B. S. G., et al. (2023). Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood | JAMA Psychiatry
Swartz, J. A., et al. (2023). Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users | Harm Reduction Journal
|